Verified Nov 2026
Other
·

Hyderabad, Telangana
·
Since 1953
Biological E. Limited, headquartered in Hyderabad, India, was founded in 1953 as India's first private-sector biologics company. With 5,000–10,000 employees and estimated revenue of $500M–$1B, it manufactures vaccines, branded formulations, and specialty generic injectables distributed across 130–140 countries. The company secured U.S. FDA approval for generic dalbavancin injection in June 2026 and serves automotive, medical, renewable-energy, and industrial sectors.
Biological E. Limited at a glance
Revenue
$500M-1B
Est. band
Employees
5,000-10,000
Founded
1953
Headquarters
Hyderabad, Telangana
Import activity
3
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
3
Named foreign suppliers
1
Top origins
Mexico

Shared foreign counterparties do not establish that these companies buy from Biological E. Limited.
What this tells a buyer
Received 15,872 shipments from Becton Dickinson De Mexico between defined periods, with Mexico as the primary origin for tracked imports.
Produces routine immunization vaccines, CORBEVAX (COVID-19), antivenoms, pediatric vaccines for tropical diseases, and specialty generic injectables; manufactures WHO pre-qualified vaccine products and is expanding into mRNA technology.
Established as India's first private-sector biological products company and currently ranks among vaccine manufacturers by production capacity.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
73 years in operation (founded 1953).
3 US import shipments on record.
Overview
Biological E. Limited, headquartered in Hyderabad, India, was founded in 1953 as India's first private-sector biologics company. With 5,000–10,000 employees and estimated revenue of $500M–$1B, it manufactures vaccines, branded formulations, and specialty generic injectables distributed across 130–140 countries. The company secured U.S. FDA approval for generic dalbavancin injection in June 2026 and serves automotive, medical, renewable-energy, and industrial sectors.
At a glance
Attribute | Detail |
|---|---|
Founded | 1953 |
Headquarters | Hyderabad, Telangana |
Employees | 5,000-10,000 |
Revenue | $500M-1B (estimated) |
What Biological E. Limited makes
Produces routine immunization vaccines, CORBEVAX (COVID-19), antivenoms, pediatric vaccines for tropical diseases, and specialty generic injectables; manufactures WHO pre-qualified vaccine products and is expanding into mRNA technology.
Trade and customs footprint
Received 15,872 shipments from Becton Dickinson De Mexico between defined periods, with Mexico as the primary origin for tracked imports. US customs bill-of-lading records list 3 inbound shipments across 1 foreign suppliers, with top origins including Mexico.
Latest developments
2026-10-14 — Building global partnerships. Enabling the next phase of biologics manufacturing. | Biological E. Limited (linkedin.com)
2026-06-18 — Biological E Becomes First Indian Company to Secure U.S. FDA Approval for Generic Dalbavancin Injection (pharmatutor.org)
2026-02-12 — Biological E Ltd || News (biologicale.com)
2025-12-09 — Telangana govt, Pharma companies inks for invest ₹9,500 cr - The HinduBusinessLine (thehindubusinessline.com)
2025-06-30 — Biological E to make HPV9 vaccine under licensing pact with Recbio | Company News - Business Standard (business-standard.com)
2025-06-05 — India’s Biological E. to supply Brazil with new pneumonia vaccine (globo.com)
Company details
Established as India's first private-sector biological products company and currently ranks among vaccine manufacturers by production capacity. Biological E. Limited was founded in 1953, has an estimated 5,000-10,000 employees, and is headquartered in Hyderabad, Telangana. On the LightSource stability read it is rated "Established & active": 73 years in operation (founded 1953). 3 US import shipments on record.
Frequently asked questions
What does Biological E. Limited do?
Biological E. Limited, headquartered in Hyderabad, India, was founded in 1953 as India's first private-sector biologics company. With 5,000–10,000 employees and estimated revenue of $500M–$1B, it manufactures vaccines, branded formulations, and specialty generic injectables distributed across 130–140 countries. The company secured U.S. FDA approval for generic dalbavancin injection in June 2026 and serves automotive, medical, renewable-energy, and industrial sectors.
Where is Biological E. Limited headquartered?
Biological E. Limited is headquartered in Hyderabad, Telangana (3, Hyderabad, Telangana, 500020).
When was Biological E. Limited founded?
Biological E. Limited was founded in 1953.
How big is Biological E. Limited?
Biological E. Limited has an estimated 5,000-10,000 employees, with revenue in the $500M-1B range (estimated).
Does Biological E. Limited import from overseas suppliers?
US customs bill-of-lading records show 3 inbound shipments for Biological E. Limited, with top origins including Mexico.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
